Skip to main content
Premium Trial:

Request an Annual Quote

Chemicon to Distribute MorphoSys Antibodies

NEW YORK, Jan. 10 (GenomeWeb News) - Serologicals subsidiary Chemicon International and MorphoSys signed a three-year agreement to distribute MorphoSys's research antibodies through Chemicon's sales network, said today.

 

Chemicon will pay MorphoSys for antibody generation, optional additional fees, and royalties on all products.

 

Under the agreement, MorphoSys's Antibodies by Design unit will develop antibodies from its HuCAL GOLD antibody library against targets identified and supplied by Chemicon. Chemicon will market the HuCal-based research antibodies as stand-alone products or as components of reagent kits.

 

The companies anticipate 100 research antibody projects per year over the life of the alliance.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.